Cargando…

Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults

IMPORTANCE: Alcohol biomarkers can improve detection of heavy alcohol use in clinical care, yet cutoffs for phosphatidylethanol (PEth), a blood biomarker, have not been established. OBJECTIVE: To determine the optimal cutoff for PEth for heavy alcohol consumption in a study of middle-age and older a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hahn, Judith A., Fatch, Robin, Barnett, Nancy P., Marcus, Gregory M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498325/
https://www.ncbi.nlm.nih.gov/pubmed/37698861
http://dx.doi.org/10.1001/jamanetworkopen.2023.33182
_version_ 1785105497827835904
author Hahn, Judith A.
Fatch, Robin
Barnett, Nancy P.
Marcus, Gregory M.
author_facet Hahn, Judith A.
Fatch, Robin
Barnett, Nancy P.
Marcus, Gregory M.
author_sort Hahn, Judith A.
collection PubMed
description IMPORTANCE: Alcohol biomarkers can improve detection of heavy alcohol use in clinical care, yet cutoffs for phosphatidylethanol (PEth), a blood biomarker, have not been established. OBJECTIVE: To determine the optimal cutoff for PEth for heavy alcohol consumption in a study of middle-age and older adults. DESIGN, SETTING, AND PARTICIPANTS: This was a 4-week diagnostic study of adults with paroxysmal atrial fibrillation (AF) and current alcohol consumption, recruited from general cardiology and cardiac electrophysiology outpatient clinics from September 2014 to September 2019. Data were analyzed from October 2021 to March 2022. MAIN OUTCOMES AND MEASURES: The main aim was to determine the optimal PEth cutoff for heavy alcohol consumption, using the Secure Continuous Remote Alcohol Monitor (SCRAM) to measure transdermal alcohol. Area under the curve (AUC) for PEth-detected compared with SCRAM-detected heavy alcohol consumption in any week over the prior 4 weeks (ie, ≥3 [women] and ≥4 [men] episodes) or any estimated breath alcohol of 0.08% or greater in any week, and the PEth cutoff was calculated using the Youden J statistic. Similar analyses were conducted comparing PEth with individual drinks reported by pressing an event monitor, retrospective self-report via the Alcohol Use Disorders Identification Test–Consumption (AUDIT-C), and using 2-week look-backs. RESULTS: In this diagnostic study of 64 patients with both PEth and SCRAM measures over 4 weeks (54 [84.4%] men; mean age, 65.5 [95% CI, 62.6-68.5] years; 51 [79.7%] White), 31 (48.4%) had any SCRAM-detected heavy alcohol consumption over the 4 weeks, and the median (IQR) PEth at 4 weeks was 23 ng/mL (<limit of quantification to 60 ng/mL). The AUC for PEth vs any SCRAM-detected heavy alcohol consumption was 0.83 (95% CI, 0.72-0.93). The optimal PEth cutoff was 18.5 ng/mL (AUC, 0.83; 95% CI, 0.72-0.93), with sensitivity of 83.9% (95% CI, 66.3%-94.5%) and specificity of 72.7% (95% CI, 54.5%-86.7%). The PEth test characteristics by individual drink reporting using the event monitors and by the AUDIT-C, and by these measures and by SCRAM collected for 2-week intervals, were similar to those compared with the 4-week SCRAM. CONCLUSIONS AND RELEVANCE: In a predominately middle-age and older White male population, PEth compared well with SCRAM. A PEth cutoff of 18.5 ng/mL (or rounded to 20 ng/mL, a recommended PEth cutoff for significant alcohol consumption) can be used in clinical care to detect heavy alcohol consumption in middle-age and older men.
format Online
Article
Text
id pubmed-10498325
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-104983252023-09-14 Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults Hahn, Judith A. Fatch, Robin Barnett, Nancy P. Marcus, Gregory M. JAMA Netw Open Original Investigation IMPORTANCE: Alcohol biomarkers can improve detection of heavy alcohol use in clinical care, yet cutoffs for phosphatidylethanol (PEth), a blood biomarker, have not been established. OBJECTIVE: To determine the optimal cutoff for PEth for heavy alcohol consumption in a study of middle-age and older adults. DESIGN, SETTING, AND PARTICIPANTS: This was a 4-week diagnostic study of adults with paroxysmal atrial fibrillation (AF) and current alcohol consumption, recruited from general cardiology and cardiac electrophysiology outpatient clinics from September 2014 to September 2019. Data were analyzed from October 2021 to March 2022. MAIN OUTCOMES AND MEASURES: The main aim was to determine the optimal PEth cutoff for heavy alcohol consumption, using the Secure Continuous Remote Alcohol Monitor (SCRAM) to measure transdermal alcohol. Area under the curve (AUC) for PEth-detected compared with SCRAM-detected heavy alcohol consumption in any week over the prior 4 weeks (ie, ≥3 [women] and ≥4 [men] episodes) or any estimated breath alcohol of 0.08% or greater in any week, and the PEth cutoff was calculated using the Youden J statistic. Similar analyses were conducted comparing PEth with individual drinks reported by pressing an event monitor, retrospective self-report via the Alcohol Use Disorders Identification Test–Consumption (AUDIT-C), and using 2-week look-backs. RESULTS: In this diagnostic study of 64 patients with both PEth and SCRAM measures over 4 weeks (54 [84.4%] men; mean age, 65.5 [95% CI, 62.6-68.5] years; 51 [79.7%] White), 31 (48.4%) had any SCRAM-detected heavy alcohol consumption over the 4 weeks, and the median (IQR) PEth at 4 weeks was 23 ng/mL (<limit of quantification to 60 ng/mL). The AUC for PEth vs any SCRAM-detected heavy alcohol consumption was 0.83 (95% CI, 0.72-0.93). The optimal PEth cutoff was 18.5 ng/mL (AUC, 0.83; 95% CI, 0.72-0.93), with sensitivity of 83.9% (95% CI, 66.3%-94.5%) and specificity of 72.7% (95% CI, 54.5%-86.7%). The PEth test characteristics by individual drink reporting using the event monitors and by the AUDIT-C, and by these measures and by SCRAM collected for 2-week intervals, were similar to those compared with the 4-week SCRAM. CONCLUSIONS AND RELEVANCE: In a predominately middle-age and older White male population, PEth compared well with SCRAM. A PEth cutoff of 18.5 ng/mL (or rounded to 20 ng/mL, a recommended PEth cutoff for significant alcohol consumption) can be used in clinical care to detect heavy alcohol consumption in middle-age and older men. American Medical Association 2023-09-12 /pmc/articles/PMC10498325/ /pubmed/37698861 http://dx.doi.org/10.1001/jamanetworkopen.2023.33182 Text en Copyright 2023 Hahn JA et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Hahn, Judith A.
Fatch, Robin
Barnett, Nancy P.
Marcus, Gregory M.
Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults
title Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults
title_full Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults
title_fullStr Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults
title_full_unstemmed Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults
title_short Phosphatidylethanol vs Transdermal Alcohol Monitoring for Detecting Alcohol Consumption Among Adults
title_sort phosphatidylethanol vs transdermal alcohol monitoring for detecting alcohol consumption among adults
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498325/
https://www.ncbi.nlm.nih.gov/pubmed/37698861
http://dx.doi.org/10.1001/jamanetworkopen.2023.33182
work_keys_str_mv AT hahnjuditha phosphatidylethanolvstransdermalalcoholmonitoringfordetectingalcoholconsumptionamongadults
AT fatchrobin phosphatidylethanolvstransdermalalcoholmonitoringfordetectingalcoholconsumptionamongadults
AT barnettnancyp phosphatidylethanolvstransdermalalcoholmonitoringfordetectingalcoholconsumptionamongadults
AT marcusgregorym phosphatidylethanolvstransdermalalcoholmonitoringfordetectingalcoholconsumptionamongadults